Fluorouracil (5FU)

DRUG3 trials

Sponsors

Hoffmann-La Roche, GlaxoSmithKline, University of Chicago

Conditions

Colorectal CancerHead and Neck CancerHead and Neck Cancer Stage IVHead and Neck Cancers - ThroatHead and Neck CarcinomaHead and Neck Squamous Cell CarcinomaNeoplasms, Head and Neck

Phase 1

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

RecruitingNCT05526924

University of ChicagoHead and Neck Cancer, Head and Neck Cancer Stage IV, Head and Neck Cancers - Throat +2

Start: 2023-03-07End: 2028-01-01Target: 30Updated: 2026-03-04

Phase 2

A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin

CompletedNCT01077739

Hoffmann-La RocheColorectal Cancer

Start: 2009-07-31End: 2012-01-31Updated: 2014-12-15

Phase 3

Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

TerminatedNCT04428333

GlaxoSmithKlineNeoplasms, Head and Neck

Start: 2020-08-12End: 2023-09-19Updated: 2024-10-09